This company has been marked as potentially delisted and may not be actively trading. RXi Pharmaceuticals (RXII) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock RXII vs. EGRX, PYRGF, LNAI, TAOX, NNVC, IBIO, AEON, NRBO, OBSV, and CPHIShould you be buying RXi Pharmaceuticals stock or one of its competitors? The main competitors of RXi Pharmaceuticals include Eagle Pharmaceuticals (EGRX), PyroGenesis Canada (PYRGF), Lunai Bioworks (LNAI), Synaptogenix (TAOX), NanoViricides (NNVC), iBio (IBIO), AEON Biopharma (AEON), NeuroBo Pharmaceuticals (NRBO), ObsEva (OBSV), and China Pharma (CPHI). RXi Pharmaceuticals vs. Its Competitors Eagle Pharmaceuticals PyroGenesis Canada Lunai Bioworks Synaptogenix NanoViricides iBio AEON Biopharma NeuroBo Pharmaceuticals ObsEva China Pharma RXi Pharmaceuticals (NASDAQ:RXII) and Eagle Pharmaceuticals (NASDAQ:EGRX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment. Does the media favor RXII or EGRX? In the previous week, Eagle Pharmaceuticals had 1 more articles in the media than RXi Pharmaceuticals. MarketBeat recorded 1 mentions for Eagle Pharmaceuticals and 0 mentions for RXi Pharmaceuticals. RXi Pharmaceuticals' average media sentiment score of 0.00 equaled Eagle Pharmaceuticals'average media sentiment score. Company Overall Sentiment RXi Pharmaceuticals Neutral Eagle Pharmaceuticals Neutral Which has more risk & volatility, RXII or EGRX? RXi Pharmaceuticals has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500. Comparatively, Eagle Pharmaceuticals has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Is RXII or EGRX more profitable? Eagle Pharmaceuticals has a net margin of 0.00% compared to RXi Pharmaceuticals' net margin of -4,990.20%. Eagle Pharmaceuticals' return on equity of 0.00% beat RXi Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets RXi Pharmaceuticals-4,990.20% -412.15% -179.54% Eagle Pharmaceuticals N/A N/A N/A Which has better valuation and earnings, RXII or EGRX? Eagle Pharmaceuticals has higher revenue and earnings than RXi Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRXi Pharmaceuticals$10K1,033.68-$12.45M-$4.20-0.56Eagle Pharmaceuticals$257.55M0.08$35.64MN/AN/A Do insiders & institutionals have more ownership in RXII or EGRX? 9.6% of RXi Pharmaceuticals shares are held by institutional investors. Comparatively, 85.4% of Eagle Pharmaceuticals shares are held by institutional investors. 1.0% of RXi Pharmaceuticals shares are held by insiders. Comparatively, 28.9% of Eagle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryEagle Pharmaceuticals beats RXi Pharmaceuticals on 8 of the 10 factors compared between the two stocks. Get RXi Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RXII and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RXII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RXII vs. The Competition Export to ExcelMetricRXi PharmaceuticalsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.34M$1.03B$6.01B$10.23BDividend YieldN/A4.84%5.66%4.70%P/E Ratio-0.561.3085.3526.57Price / Sales1,033.6830.60584.94179.70Price / CashN/A17.6438.3262.20Price / Book3.067.3112.726.53Net Income-$12.45M-$7.96M$3.30B$275.96M RXi Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RXIIRXi PharmaceuticalsN/A$2.36-2.5%N/A-13.9%$10.34M$10K-0.56N/AEGRXEagle Pharmaceuticals1.3512 of 5 stars$3.00flatN/A+72.0%$38.96M$257.55M0.00100Gap DownPYRGFPyroGenesis CanadaN/A$0.18+0.4%N/A-70.0%$34.49M$9.14M-3.0790Gap DownLNAILunai BioworksN/A$1.24-1.6%N/AN/A$28.74MN/A-0.1620Analyst ForecastTAOXSynaptogenix0.1853 of 5 stars$7.75+7.3%N/AN/A$27.05MN/A-0.384News CoverageAnalyst ForecastGap UpNNVCNanoViricides0.0891 of 5 stars$1.44+1.1%N/A+3.3%$25.01MN/A-1.9920IBIOiBio2.2508 of 5 stars$0.86-0.6%$5.00+478.7%-69.8%$16.96M$400K-0.50100AEONAEON Biopharma0.9274 of 5 stars$0.94+0.8%N/A-98.7%$10.98MN/A5.245Analyst ForecastGap UpNRBONeuroBo PharmaceuticalsN/A$1.06-1.9%N/A-59.6%$9.13MN/A0.0010Gap DownHigh Trading VolumeOBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050CPHIChina PharmaN/A$1.98+1.0%N/A-91.7%$6.46M$4.40M0.00250Gap Down Related Companies and Tools Related Companies EGRX Alternatives PYRGF Alternatives LNAI Alternatives TAOX Alternatives NNVC Alternatives IBIO Alternatives AEON Alternatives NRBO Alternatives OBSV Alternatives CPHI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RXII) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored"I'm risking my reputation on this"If I'm right about what's coming, this could be the most important book you'll read this yearCrypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RXi Pharmaceuticals Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share RXi Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
